STEPHANIE DURHAM: Open Payments
NPI 1306356183 · NEWKIRK, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$288 in 15 payments from 7 companies in 2025. Trend: 2023 $100 · 2024 $215 · 2025 $288
Food & beverage: $288
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $71 |
| E.R. Squibb & Sons, L.L.C. | 3 | $57 |
| ABBVIE INC. | 3 | $52 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Alkermes, Inc. | 1 | $27 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
Products named: CAPLYTA, COBENFY, VRAYLAR, REXULTI, ARISTADA, AUSTEDO XR, Qelbree, UZEDY.
Industry payments across OK — which companies pay providers there.
